Tags

Type your tag names separated by a space and hit enter

[Evaluation of beta-adrenergic blockader therapy in vasovagal syncope reproduced by head-up tilt test].
Arch Mal Coeur Vaiss. 1991 Oct; 84(10):1453-7.AM

Abstract

Increased sympathetic tone is one physiopathological mechanism of vasovagal syncope. In this case, betablocker therapy is logical. The reports in the literature suggest that the head-up tilt test can reliably reproduce vasovagal syncope. Ten patients (4 men and 6 women, mean age 59 +/- 18 years) who suffered from recurrent vasovagal syncopes (2 to 10 attacks in 6 patients and more than 10 in the other 4) with a positive initial head-up tilt test (syncope or severe dizziness with marked hypotension after a maximum of 40 minutes at 60 degrees) were treated with atenolol (200 mg daily in 7 cases and 100 mg daily in the other 3). A second head-up tilt test was performed 15 +/- 6 days later under betablocker therapy; this test was negative in 7 and remained positive in 3 cases. Irrespective of the result, the 10 patients followed the same therapy at the same dosage. After 9 +/- 5 months, 3 patients had another syncopal attack; 2 stopped taking their medication and the third patient continued the betablocker because there was a marked reduction in the frequency of his attacks. There were no further syncopal episodes during follow-up of the other 7 patients. The medium-term efficacy could not be predicted from the results of the second head-up tilt test. The following conclusions may be drawn from this study: The head-up tilt test becomes negative in 70% of cases after introducing betablocker therapy, assuming a 100% reproductivity. This treatment is effective in over half the patients at medium term and should be considered in patients with recurrent vasovagal syncope.

Authors+Show Affiliations

Service de cardiologie Himbert, hôpital Morvan, CHU Brest.No affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

English Abstract
Journal Article

Language

fre

PubMed ID

1684700

Citation

Blanc, J J., et al. "[Evaluation of Beta-adrenergic Blockader Therapy in Vasovagal Syncope Reproduced By Head-up Tilt Test]." Archives Des Maladies Du Coeur Et Des Vaisseaux, vol. 84, no. 10, 1991, pp. 1453-7.
Blanc JJ, Corbel C, Mansourati J, et al. [Evaluation of beta-adrenergic blockader therapy in vasovagal syncope reproduced by head-up tilt test]. Arch Mal Coeur Vaiss. 1991;84(10):1453-7.
Blanc, J. J., Corbel, C., Mansourati, J., & Genet, L. (1991). [Evaluation of beta-adrenergic blockader therapy in vasovagal syncope reproduced by head-up tilt test]. Archives Des Maladies Du Coeur Et Des Vaisseaux, 84(10), 1453-7.
Blanc JJ, et al. [Evaluation of Beta-adrenergic Blockader Therapy in Vasovagal Syncope Reproduced By Head-up Tilt Test]. Arch Mal Coeur Vaiss. 1991;84(10):1453-7. PubMed PMID: 1684700.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Evaluation of beta-adrenergic blockader therapy in vasovagal syncope reproduced by head-up tilt test]. AU - Blanc,J J, AU - Corbel,C, AU - Mansourati,J, AU - Genet,L, PY - 1991/10/1/pubmed PY - 1991/10/1/medline PY - 1991/10/1/entrez SP - 1453 EP - 7 JF - Archives des maladies du coeur et des vaisseaux JO - Arch Mal Coeur Vaiss VL - 84 IS - 10 N2 - Increased sympathetic tone is one physiopathological mechanism of vasovagal syncope. In this case, betablocker therapy is logical. The reports in the literature suggest that the head-up tilt test can reliably reproduce vasovagal syncope. Ten patients (4 men and 6 women, mean age 59 +/- 18 years) who suffered from recurrent vasovagal syncopes (2 to 10 attacks in 6 patients and more than 10 in the other 4) with a positive initial head-up tilt test (syncope or severe dizziness with marked hypotension after a maximum of 40 minutes at 60 degrees) were treated with atenolol (200 mg daily in 7 cases and 100 mg daily in the other 3). A second head-up tilt test was performed 15 +/- 6 days later under betablocker therapy; this test was negative in 7 and remained positive in 3 cases. Irrespective of the result, the 10 patients followed the same therapy at the same dosage. After 9 +/- 5 months, 3 patients had another syncopal attack; 2 stopped taking their medication and the third patient continued the betablocker because there was a marked reduction in the frequency of his attacks. There were no further syncopal episodes during follow-up of the other 7 patients. The medium-term efficacy could not be predicted from the results of the second head-up tilt test. The following conclusions may be drawn from this study: The head-up tilt test becomes negative in 70% of cases after introducing betablocker therapy, assuming a 100% reproductivity. This treatment is effective in over half the patients at medium term and should be considered in patients with recurrent vasovagal syncope. SN - 0003-9683 UR - https://www.unboundmedicine.com/medline/citation/1684700/[Evaluation_of_beta_adrenergic_blockader_therapy_in_vasovagal_syncope_reproduced_by_head_up_tilt_test]_ DB - PRIME DP - Unbound Medicine ER -